Lysis refers to the breaking down of the membrane of a cell, often by viral, enzymic, or osmotic mechanisms that compromise its integrity. A fluid containing the contents of lysed cells is called a lysate. Cell disruption is a method or process for releasing biological molecules from inside a cell.
The market is growing because the higher adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products.

Market Analysis and Insights: Global Cell Lysis & Disruption Market
The global Cell Lysis & Disruption market size is projected to reach US$ 131.1 million by 2027, from US$ 91 million in 2020, at a CAGR of 4.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Lysis & Disruption market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Lysis & Disruption market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Lysis & Disruption market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Lysis & Disruption market.

Global Cell Lysis & Disruption Scope and Market Size
Cell Lysis & Disruption market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Lysis & Disruption market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mammalian cells
Bacterial cells
Yeast/Algae/Fungi
Plant cells

Segment by Application
Protein Isolation
Downstream Processing
Cell Organelle Isolation
Nucleic Acid Isolation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd
Qiagen NV
Becton Dickinson & Company (BD)
Danaher Corporation
Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH
Claremont BioSolutions, LLC
Microfluidics International Corporation
Parr Instrument Company
BioVision, Inc.
Covaris, Inc.
Qsonica LLC